Task 2 Sample

Yes Cancer samples:

study interventions are Erlotinib Hydrochloride . precancerous condition diagnosis and disease characteristics

study interventions are Docetaxel . recurrent non small cell lung carcinoma diagnosis and arm cohort four

study interventions are Cisplatin . esophageal cancer diagnosis and pulmonary

study interventions are Doxorubicin . breast cancer diagnosis and life expectancy

study interventions are Cisplatin . brain tumors diagnosis and hematopoietic


No Cancer samples:

study interventions are Dasatinib . head and neck cancer diagnosis and concomitant medications any of the following should be considered for exclusion

study interventions are Carboplatin . recurrent childhood grade iii lymphomatoid granulomatosis diagnosis and no serious medical or psychiatric illness

study interventions are Carboplatin . stage iv non small cell lung cancer diagnosis and known history of allergic reactions to paclitaxel

study interventions are SAR302503 (TG101348) . men who partner with woman of childbearing potential unless they agree to use effective contraception while on study drug

study interventions are S-1 for 6 months . suffering from other uncontrolled diseases such as other tumors acute and chronic infection